Stay updated on Efficacy of Dupilumab in EoE Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Dupilumab in EoE Clinical Trial page.

Latest updates to the Efficacy of Dupilumab in EoE Clinical Trial page
- Check2 days agoChange DetectedThe site revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the dupilumab study in adult and adolescent patients with eosinophilic esophagitis is displayed, with study details and supporting research information.SummaryDifference100%

- Check16 days agoChange DetectedThe page continues to show a 403 Forbidden error instead of the study record. The footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check30 days agoChange DetectedA notice about NIH’s website terminology transition was added above the ClinicalTrials.gov page, and the site revision label advanced from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check44 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link instead of the study record content. This indicates an access/permissions issue that blocks viewing the study details.SummaryDifference20%

Stay in the know with updates to Efficacy of Dupilumab in EoE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Dupilumab in EoE Clinical Trial page.